The roller coaster ride continues.
Here's why this team of biotech experts are giddy about these stocks right now.
Traders cheer after the company reports a regulatory win.
Shares jump after the company receives some love from the analyst community.
It can be tough to pick winners in the world of pharmaceutical development, but Alexion, Regeneron, and Ionis offer investors good chances of strong returns.
Find out why Cardinal Health, CannTrust Holdings, and Abiomed have our healthcare experts feeling giddy right now.
These three businesses are a great way for investors to support the war on cancer.
Shares shoot higher after the company reports upbeat earnings.
You probably haven't heard of any of these businesses, but they're worth a look.
Here's why ViewRay, Nevro, and LaMaitre Vascular could all be great healthcare stocks to own.
Slack has amazing long-term potential. Unfortunately, the market already knows it.
All of the company's key metrics are heading in the right direction.
Shockwave Medical's stock market debut got buried amid the recent surge of better-known offerings, but we’re digging this gem back out.
Shares jump after the company posts a strong start to the fiscal year and boost guidance.
Shares nose-dive after the company announces a surprise acquisition. Here's what investors need to know.
The visual search engine has been public for about a month. Is this a growth story that should excite investors?
Even geopolitical uncertainty can't slow the specialty software maker down.
Pinterest, DocuSign, and Upwork have had three very different entries to the market.
Which retail pharma giant is the better choice for investors today?
Shares slid after the company reported mixed first-quarter results and issued tepid guidance. Here's what investors need to know.